Abstract
Epithelial-to-mesenchymal transition (EMT) is closely linked to conversion of early-stage tumours into invasive malignancies. Many signalling pathways are involved in EMT, but the key regulatory kinases in this important process have not been clearly identified. Protein kinase CK2 is a multi-subunit protein kinase, which, when overexpressed, has been linked to disease progression and poor prognosis in various cancers. Specifically, overexpression of CK2α in human breast cancers is correlated with metastatic risk. In this article, we show that an imbalance of CK2 subunits reflected by a decrease in the CK2β regulatory subunit in a subset of breast tumour samples is correlated with induction of EMT-related markers. CK2β-depleted epithelial cells displayed EMT-like morphological changes, enhanced migration, and anchorage-independent growth, all of which require Snail1 induction. In epithelial cells, Snail1 stability is negatively regulated by CK2 and GSK3β through synergistic hierarchal phosphorylation. This process depends strongly on CK2β, thus confirming that CK2 functions upstream of Snail1. In primary breast tumours, CK2β underexpression also correlates strongly with expression of EMT markers, emphasizing the link between asymmetric expression of CK2 subunits and EMT in vivo. Our results therefore highlight the importance of CK2β in controlling epithelial cell plasticity. They show that CK2 holoenzyme activity is essential to suppress EMT, and that it contributes to maintaining a normal epithelial morphology. This study also suggests that unbalanced expression of CK2 subunits may drive EMT, thereby contributing to tumour progression.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Accession codes
References
Savagner P . Leaving the neighborhood: molecular mechanisms involved during epithelial-mesenchymal transition. Bioessays 2001; 23: 912–923.
Thiery JP . Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer 2002; 2: 442–454.
Moustakas A, Heldin CH . Signaling networks guiding epithelial-mesenchymal transitions during embryogenesis and cancer progression. Cancer Sci 2007; 98: 1512–1520.
Thiery JP . Cell adhesion in development: a complex signaling network. Curr Opin Genet Dev 2003; 13: 365–371.
Morel AP, Lievre M, Thomas C, Hinkal G, Ansieau S, Puisieux A . Generation of breast cancer stem cells through epithelial-mesenchymal transition. PLoS One 2008; 3: e2888.
Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan A, Zhou AY et al. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 2008; 133: 704–715.
Sullivan NJ, Sasser AK, Axel AE, Vesuna F, Raman V, Ramirez N et al. Interleukin-6 induces an epithelial-mesenchymal transition phenotype in human breast cancer cells. Oncogene 2009; 28: 2940–2947.
Gort EH, Groot AJ, van der Wall E, van Diest PJ, Vooijs MA . Hypoxic regulation of metastasis via hypoxia-inducible factors. Curr Mol Med 2008; 8: 60–67.
Thiery JP, Acloque H, Huang RY, Nieto MA . Epithelial-mesenchymal transitions in development and disease. Cell 2009; 139: 871–890.
Moustakas A, Heldin CH . Non-Smad TGF-beta signals. J Cell Sci 2005; 118 (Part 16) 3573–3584.
Peinado H, Olmeda D, Cano A . Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype? Nat Rev Cancer 2007; 7: 415–428.
de Herreros AG, Peiro S, Nassour M, Savagner P . Snail family regulation and epithelial mesenchymal transitions in breast cancer progression. J Mammary Gland Biol Neoplasia 2010; 15: 135–147.
MacPherson MR, Molina P, Souchelnytskyi S, Wernstedt C, Martin-Perez J, Portillo F et al. Phosphorylation of serine 11 and serine 92 as new positive regulators of human Snail1 function: potential involvement of casein kinase-2 and the cAMP-activated kinase protein kinase A. Mol Biol Cell 2010; 21: 244–253.
Cochet C, Chambaz EM . Oligomeric structure and catalytic activity of G type casein kinase. Isolation of the two subunits and renaturation experiments. J Biol Chem 1983; 258: 1403–1406.
Buchou T, Vernet M, Blond O, Jensen HH, Pointu H, Olsen BB et al. Disruption of the regulatory beta subunit of protein kinase CK2 in mice leads to a cell-autonomous defect and early embryonic lethality. Mol Cell Biol 2003; 23: 908–915.
Filhol O, Nueda A, Martel V, Gerber-Scokaert D, Benitez MJ, Souchier C et al. Live-cell fluorescence imaging reveals the dynamics of protein kinase CK2 individual subunits. Mol Cell Biol 2003; 23: 975–987.
Filhol O, Cochet C . Protein kinase CK2 in health and disease: Cellular functions of protein kinase CK2: a dynamic affair. Cell Mol Life Sci 2009; 66: 1830–1839.
Gyenis L, Litchfield DW . The emerging CK2 interactome: insights into the regulation and functions of CK2. Mol Cell Biochem 2008; 316: 5–14.
Huillard E, Ziercher L, Blond O, Wong M, Deloulme JC, Souchelnytskyi S et al. Disruption of CK2beta in embryonic neural stem cells compromises proliferation and oligodendrogenesis in the mouse telencephalon. Mol Cell Biol 2010; 30: 2737–2749.
Poletto G, Vilardell J, Marin O, Pagano MA, Cozza G, Sarno S et al. The regulatory beta subunit of protein kinase CK2 contributes to the recognition of the substrate consensus sequence. A study with an eIF2beta-derived peptide. Biochemistry 2008; 47: 8317–8325.
Canton DA, Litchfield DW . The shape of things to come: an emerging role for protein kinase CK2 in the regulation of cell morphology and the cytoskeleton. Cell Signal 2006; 18: 267–275.
Deshiere A, Theis-Febvre N, Martel V, Cochet C, Filhol O . Protein kinase CK2 and cell polarity. Mol Cell Biochem 2008; 316: 107–113.
Ji H, Wang J, Nika H, Hawke D, Keezer S, Ge Q et al. EGF-induced ERK activation promotes CK2-mediated disassociation of alpha-Catenin from beta-Catenin and transactivation of beta-Catenin. Mol Cell 2009; 36: 547–559.
Lilien J, Balsamo J . The regulation of cadherin-mediated adhesion by tyrosine phosphorylation/dephosphorylation of beta-catenin. Curr Opin Cell Biol 2005; 17: 459–465.
Bek S, Kemler R . Protein kinase CKII regulates the interaction of beta-catenin with alpha-catenin and its protein stability. J Cell Sci 2002; 115 (Part 24) 4743–4753.
Wu H, Symes K, Seldin DC, Dominguez I . Threonine 393 of beta-catenin regulates interaction with Axin. J Cell Biochem 2009; 108: 52–63.
Landesman-Bollag E, Romieu-Mourez R, Song DH, Sonenshein GE, Cardiff RD, Seldin DC . Protein kinase CK2 in mammary gland tumorigenesis. Oncogene 2001; 20: 3247–3257.
Rozanov DV, Savinov AY, Williams R, Liu K, Golubkov VS, Krajewski S et al. Molecular signature of MT1-MMP: transactivation of the downstream universal gene network in cancer. Cancer Res 2008; 68: 4086–4096.
Giusiano S, Cochet C, Filhol O, Duchemin-Pelletier E, Secq V, Bonnier P et al. Protein kinase CK2alpha subunit over-expression correlates with metastatic risk in breast carcinomas: quantitative immunohistochemistry in tissue microarrays. Eur J Cancer 2011; 47: 792–801.
Romieu-Mourez R, Landesman-Bollag E, Seldin DC, Sonenshein GE . Protein kinase CK2 promotes aberrant activation of nuclear factor-kappaB, transformed phenotype, and survival of breast cancer cells. Cancer Res 2002; 62: 6770–6778.
Blanco MJ, Moreno-Bueno G, Sarrio D, Locascio A, Cano A, Palacios J et al. Correlation of Snail expression with histological grade and lymph node status in breast carcinomas. Oncogene 2002; 21: 3241–3246.
Trimboli AJ, Fukino K, de Bruin A, Wei G, Shen L, Tanner SM et al. Direct evidence for epithelial-mesenchymal transitions in breast cancer. Cancer Res 2008; 68: 937–945.
Hennessy BT, Gonzalez-Angulo AM, Stemke-Hale K, Gilcrease MZ, Krishnamurthy S, Lee JS et al. Characterization of a naturally occurring breast cancer subset enriched in epithelial-to-mesenchymal transition and stem cell characteristics. Cancer Res 2009; 69: 4116–4124.
Charafe-Jauffret E, Ginestier C, Monville F, Finetti P, Adelaide J, Cervera N et al. Gene expression profiling of breast cell lines identifies potential new basal markers. Oncogene 2006; 25: 2273–2284.
Sarrio D, Rodriguez-Pinilla SM, Hardisson D, Cano A, Moreno-Bueno G, Palacios J . Epithelial-mesenchymal transition in breast cancer relates to the basal-like phenotype. Cancer Res 2008; 68: 989–997.
Deshiere A, Duchemin-Pelletier E, Spreux E, Ciais D, Forcet C, Cochet C et al. Regulation of epithelial to mesenchymal transition:CK2β on stage. Mol Cell Biochem 2011; 316: 107–113.
Seton-Rogers SE, Lu Y, Hines LM, Koundinya M, LaBaer J, Muthuswamy SK et al. Cooperation of the ErbB2 receptor and transforming growth factor beta in induction of migration and invasion in mammary epithelial cells. Proc Natl Acad Sci USA 2004; 101: 1257–1262.
Peinado H, Quintanilla M, Cano A . Transforming growth factor beta-1 induces snail transcription factor in epithelial cell lines: mechanisms for epithelial mesenchymal transitions. J Biol Chem 2003; 278: 21113–21123.
Bibby AC, Litchfield DW . The multiple personalities of the regulatory subunit of protein kinase CK2: CK2 dependent and CK2 independent roles reveal a secret identity for CK2beta. Int J Biol Sci 2005; 1: 67–79.
Zhou BP, Deng J, Xia W, Xu J, Li YM, Gunduz M et al. Dual regulation of Snail by GSK-3beta-mediated phosphorylation in control of epithelial-mesenchymal transition. Nat Cell Biol 2004; 6: 931–940.
Xu Y, Lee SH, Kim HS, Kim NH, Piao S, Park SH et al. Role of CK1 in GSK3beta-mediated phosphorylation and degradation of Snail. Oncogene 2010; 29: 3124–3133.
Romieu-Mourez R, Landesman-Bollag E, Seldin DC, Traish AM, Mercurio F, Sonenshein GE . Roles of IKK kinases and protein kinase CK2 in activation of nuclear factor-kappaB in breast cancer. Cancer Res 2001; 61: 3810–3818.
Mottet D, Ruys SP, Demazy C, Raes M, Michiels C . Role for casein kinase 2 in the regulation of HIF-1 activity. Int J Cancer 2005; 117: 764–774.
Pluemsampant S, Safronova OS, Nakahama K, Morita I . Protein kinase CK2 is a key activator of histone deacetylase in hypoxia-associated tumours. Int J Cancer 2008; 122: 333–341.
Hill RP, Marie-Egyptienne DT, Hedley DW . Cancer stem cells, hypoxia and metastasis. Semin Radiat Oncol 2009; 19: 106–111.
Simpson KJ, Selfors LM, Bui J, Reynolds A, Leake D, Khvorova A et al. Identification of genes that regulate epithelial cell migration using an siRNA screening approach. Nat Cell Biol 2008; 10: 1027–1038.
de Herreros AG, Peiro S, Nassour M, Savagner P . Snail family regulation and epithelial mesenchymal transitions in breast cancer progression. J Mammary Gland Biol Neoplasia 2010; 15: 135–147.
Bachelder RE, Yoon SO, Franci C, de Herreros AG, Mercurio AM . Glycogen synthase kinase-3 is an endogenous inhibitor of Snail transcription: implications for the epithelial-mesenchymal transition. J Cell Biol 2005; 168: 29–33.
Taube JH, Herschkowitz JI, Komurov K, Zhou AY, Gupta S, Yang J et al. Core epithelial-to-mesenchymal transition interactome gene-expression signature is associated with claudin-low and metaplastic breast cancer subtypes. Proc Natl Acad Sci USA 2010; 107: 15449–15454.
Bissell MJ, Hines WC . Why don't we get more cancer? A proposed role of the microenvironment in restraining cancer progression. Nat Med 2011; 17: 320–329.
Bussard KM, Boulanger CA, Booth BW, Bruno RD, Smith GH . Reprogramming human cancer cells in the mouse mammary gland. Cancer Res 2010; 70: 6336–6343.
Debnath J, Muthuswamy SK, Brugge JS . Morphogenesis and oncogenesis of MCF-10A mammary epithelial acini grown in three-dimensional basement membrane cultures. Methods 2003; 30: 256–268.
Laramas M, Pasquier D, Filhol O, Ringeisen F, Descotes JL, Cochet C . Nuclear localization of protein kinase CK2 catalytic subunit (CK2alpha) is associated with poor prognostic factors in human prostate cancer. Eur J Cancer 2007; 43: 928–934.
Barbera MJ, Puig I, Dominguez D, Julien-Grille S, Guaita-Esteruelas S, Peiro S et al. Regulation of Snail transcription during epithelial to mesenchymal transition of tumour cells. Oncogene 2004; 23: 7345–7354.
Charpin C, Secq V, Giusiano S, Carpentier S, Andrac L, Lavaut MN et al. A signature predictive of disease outcome in breast carcinomas, identified by quantitative immunocytochemical assays. Int J Cancer 2009; 124: 2124–2134.
Acknowledgements
This research was supported by recurrent institutional funding from INSERM, CEA, Ligue Nationale contre le Cancer (accredited team 2010-2012), UJF, and grants from the French National Research Agency (PCV-08 CoCCINet), ARC. We thank L Larue and BP Zhou for promoter reporter constructs, AG de Herreros for Snail1 antibody, M Théry and S Ansieau for critical reading of the manuscript.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Additional information
Supplementary Information accompanies the paper on the Oncogene website
Supplementary information
Rights and permissions
About this article
Cite this article
Deshiere, A., Duchemin-Pelletier, E., Spreux, E. et al. Unbalanced expression of CK2 kinase subunits is sufficient to drive epithelial-to-mesenchymal transition by Snail1 induction. Oncogene 32, 1373–1383 (2013). https://doi.org/10.1038/onc.2012.165
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/onc.2012.165
Keywords
This article is cited by
-
Protein kinase CK2 – diverse roles in cancer cell biology and therapeutic promise
Molecular and Cellular Biochemistry (2023)
-
Protein kinase CK2: a potential therapeutic target for diverse human diseases
Signal Transduction and Targeted Therapy (2021)
-
Protein kinase CK2 contributes to placental development: physiological and pathological implications
Journal of Molecular Medicine (2020)
-
Discovery of holoenzyme-disrupting chemicals as substrate-selective CK2 inhibitors
Scientific Reports (2019)
-
Identifying global expression patterns and key regulators in epithelial to mesenchymal transition through multi-study integration
BMC Cancer (2017)